Arteris (AIP) CEO Janac gets 78,051 RSUs and gifts 70,000 shares
Rhea-AI Filing Summary
Arteris, Inc. director and President and CEO K. Charles Janac reported multiple equity movements involving the company’s common stock. On February 18, 2026, he acquired 78,051 shares through a grant of restricted stock units, at a stated price of $0.0000 per share.
According to the footnotes, each RSU represents one share of common stock and will vest as to 1/16 of the total on April 1, 2026, then in equal quarterly installments thereafter, with no expiration date. After this grant, his directly held common stock position was 217,538 shares.
On February 20, 2026, Bayview Legacy, LLC, an entity for which Janac serves as manager with voting and dispositive power, made a bona fide gift of 70,000 common shares at a reported price of $0.0000 per share, leaving 9,279,071 shares indirectly held through that LLC. A separate line item shows 56,252 shares held indirectly by the Charles and Lydia Janac Trust, for which he serves as trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 70,000 | $0.00 | -- |
| Grant/Award | Common Stock | 78,051 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes 78,051 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 1/16th of the total RSUs on 4/1/2026 and in equal quarterly installments thereafter. The RSUs have no expiration date. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.